Simmie White is taking control of her own story. The six-year-old girl and her mother want others to understand more about ...
Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Good morning, and welcome to Agios’ Fourth Quarter 2024 ...
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
The Urban League of Greater Madison and The American Red Cross will host a Sickle Cell Awareness Blood Drive on Saturday, Feb ...
Flow Space on MSN1d
Black Women Leading the Charge in Healthcare: Meet 3 Pioneering Doctors Tackling DisparitiesThese physicians have dedicated their careers to fighting for health equity, ensuring that quality care isn't just a ...
An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.
In honor of Black History Month, we're covering five milestones in Black health history, from the good and great to the bad and ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
2d
WCIV Charleston on MSNGene therapy among cutting-edge treatments at MUSC's new sickle cell center in CharlestonThe Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...
2don MSN
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.
Nike’s decision to partner with Skims comes as it looks to claw back market share and return to growth under new CEO Elliott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results